Viyash Scientific

Pharmaceuticals & Drugs · Pharmaceuticals

SeQuent is looking towards the future with courage and confidence, because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint, operating in the domains of Animal Health (API and formulation). The company branded its Animal Health business as Alivira Animal Health with a singular focus to create value in the global animal health space. It caters to unaddressed global market requirements and focus on products for livestock, pou

—
Credibility score
no completed guidance cycle yet
0
Promises scored
guidance judged against delivery
5
Live targets
open guidance being tracked

What GuideTrack tracks for Viyash Scientific

Every earnings call is read for the annual guidance management gives — revenue growth, revenue in rupees, and margins — with the verbatim quote and who said it. When the year closes, each promise is scored against what was actually delivered. Calls processed so far: Q4FY24, Q4FY25, Q4FY26.

  • The exact figure management guided, and the sentence they said it in
  • Whether the number was later raised, lowered or quietly dropped
  • What was delivered, and the achievement score for each year
  • Quarterly on-track / at-risk / off-track updates through the year

GuideTrack is a research tool. Nothing here is investment advice or a recommendation to buy or sell Viyash Scientific. Our extraction is AI-assisted and can make mistakes — always check the company's own filings.